Global Human Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Human Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Human Rabies Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Human Rabies Vaccine Market Size Growth Rate by Type
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Market by Application
1.3.1 Global Human Rabies Vaccine Market Size Growth Rate by Application
1.3.2 Pre-Exposure Vaccine
1.3.3 Post-Exposure Vaccine
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Rabies Vaccine Market Size Estimates and Forecasts
2.1.1 Global Human Rabies Vaccine Revenue 2016-2027
2.1.2 Global Human Rabies Vaccine Sales 2016-2027
2.2 Human Rabies Vaccine Market Size by Region: 2021 Versus 2027
2.3 Human Rabies Vaccine Sales by Region (2016-2027)
2.3.1 Global Human Rabies Vaccine Sales by Region: 2016-2021
2.3.2 Global Human Rabies Vaccine Sales Forecast by Region (2022-2027)
2.3.3 Global Human Rabies Vaccine Sales Market Share by Region (2016-2027)
2.4 Human Rabies Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Human Rabies Vaccine Revenue by Region: 2016-2021
2.4.2 Global Human Rabies Vaccine Revenue Forecast by Region (2022-2027)
2.4.3 Global Human Rabies Vaccine Revenue Market Share by Region (2016-2027)
3 Global Human Rabies Vaccine by Manufacturers
3.1 Global Top Human Rabies Vaccine Manufacturers by Sales
3.1.1 Global Human Rabies Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Human Rabies Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Human Rabies Vaccine Manufacturers by Revenue
3.2.1 Global Human Rabies Vaccine Revenue by Manufacturer (2016-2021)
3.2.2 Global Human Rabies Vaccine Revenue Share by Manufacturer (2016-2021)
3.3 Global Human Rabies Vaccine Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Human Rabies Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Human Rabies Vaccine Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Human Rabies Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Human Rabies Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Human Rabies Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Human Rabies Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Bharat Biotech
4.1.1 Bharat Biotech Corporation Information
4.1.2 Bharat Biotech Description, Business Overview
4.1.3 Bharat Biotech Human Rabies Vaccine Products Offered
4.1.4 Bharat Biotech Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Bharat Biotech Human Rabies Vaccine Revenue by Product
4.1.6 Bharat Biotech Human Rabies Vaccine Revenue by Application
4.1.7 Bharat Biotech Human Rabies Vaccine Revenue by Geographic Area
4.1.8 Bharat Biotech Human Rabies Vaccine Revenue by Sales Channel
4.1.9 Bharat Biotech Recent Development
4.2 Bavarian Nordic
4.2.1 Bavarian Nordic Corporation Information
4.2.2 Bavarian Nordic Description, Business Overview
4.2.3 Bavarian Nordic Human Rabies Vaccine Products Offered
4.2.4 Bavarian Nordic Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Bavarian Nordic Human Rabies Vaccine Revenue by Product
4.2.6 Bavarian Nordic Human Rabies Vaccine Revenue by Application
4.2.7 Bavarian Nordic Human Rabies Vaccine Revenue by Geographic Area
4.2.8 Bavarian Nordic Human Rabies Vaccine Revenue by Sales Channel
4.2.9 Bavarian Nordic Recent Development
4.3 Sanofi-Pasteur
4.3.1 Sanofi-Pasteur Corporation Information
4.3.2 Sanofi-Pasteur Description, Business Overview
4.3.3 Sanofi-Pasteur Human Rabies Vaccine Products Offered
4.3.4 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Sanofi-Pasteur Human Rabies Vaccine Revenue by Product
4.3.6 Sanofi-Pasteur Human Rabies Vaccine Revenue by Application
4.3.7 Sanofi-Pasteur Human Rabies Vaccine Revenue by Geographic Area
4.3.8 Sanofi-Pasteur Human Rabies Vaccine Revenue by Sales Channel
4.3.9 Sanofi-Pasteur Recent Development
4.4 Chengda Bio
4.4.1 Chengda Bio Corporation Information
4.4.2 Chengda Bio Description, Business Overview
4.4.3 Chengda Bio Human Rabies Vaccine Products Offered
4.4.4 Chengda Bio Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Chengda Bio Human Rabies Vaccine Revenue by Product
4.4.6 Chengda Bio Human Rabies Vaccine Revenue by Application
4.4.7 Chengda Bio Human Rabies Vaccine Revenue by Geographic Area
4.4.8 Chengda Bio Human Rabies Vaccine Revenue by Sales Channel
4.4.9 Chengda Bio Recent Development
4.5 KANGH
4.5.1 KANGH Corporation Information
4.5.2 KANGH Description, Business Overview
4.5.3 KANGH Human Rabies Vaccine Products Offered
4.5.4 KANGH Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.5.5 KANGH Human Rabies Vaccine Revenue by Product
4.5.6 KANGH Human Rabies Vaccine Revenue by Application
4.5.7 KANGH Human Rabies Vaccine Revenue by Geographic Area
4.5.8 KANGH Human Rabies Vaccine Revenue by Sales Channel
4.5.9 KANGH Recent Development
4.6 Prcmise
4.6.1 Prcmise Corporation Information
4.6.2 Prcmise Description, Business Overview
4.6.3 Prcmise Human Rabies Vaccine Products Offered
4.6.4 Prcmise Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Prcmise Human Rabies Vaccine Revenue by Product
4.6.6 Prcmise Human Rabies Vaccine Revenue by Application
4.6.7 Prcmise Human Rabies Vaccine Revenue by Geographic Area
4.6.8 Prcmise Recent Development
4.7 Henan Grand Biopharma
4.7.1 Henan Grand Biopharma Corporation Information
4.7.2 Henan Grand Biopharma Description, Business Overview
4.7.3 Henan Grand Biopharma Human Rabies Vaccine Products Offered
4.7.4 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Henan Grand Biopharma Human Rabies Vaccine Revenue by Product
4.7.6 Henan Grand Biopharma Human Rabies Vaccine Revenue by Application
4.7.7 Henan Grand Biopharma Human Rabies Vaccine Revenue by Geographic Area
4.7.8 Henan Grand Biopharma Recent Development
4.8 Zhuoyi Biological
4.8.1 Zhuoyi Biological Corporation Information
4.8.2 Zhuoyi Biological Description, Business Overview
4.8.3 Zhuoyi Biological Human Rabies Vaccine Products Offered
4.8.4 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Zhuoyi Biological Human Rabies Vaccine Revenue by Product
4.8.6 Zhuoyi Biological Human Rabies Vaccine Revenue by Application
4.8.7 Zhuoyi Biological Human Rabies Vaccine Revenue by Geographic Area
4.8.8 Zhuoyi Biological Recent Development
4.9 ZhongKe Biopharm
4.9.1 ZhongKe Biopharm Corporation Information
4.9.2 ZhongKe Biopharm Description, Business Overview
4.9.3 ZhongKe Biopharm Human Rabies Vaccine Products Offered
4.9.4 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.9.5 ZhongKe Biopharm Human Rabies Vaccine Revenue by Product
4.9.6 ZhongKe Biopharm Human Rabies Vaccine Revenue by Application
4.9.7 ZhongKe Biopharm Human Rabies Vaccine Revenue by Geographic Area
4.9.8 ZhongKe Biopharm Recent Development
4.10 Ningbo Rongan Biological
4.10.1 Ningbo Rongan Biological Corporation Information
4.10.2 Ningbo Rongan Biological Description, Business Overview
4.10.3 Ningbo Rongan Biological Human Rabies Vaccine Products Offered
4.10.4 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Ningbo Rongan Biological Human Rabies Vaccine Revenue by Product
4.10.6 Ningbo Rongan Biological Human Rabies Vaccine Revenue by Application
4.10.7 Ningbo Rongan Biological Human Rabies Vaccine Revenue by Geographic Area
4.10.8 Ningbo Rongan Biological Recent Development
4.11 Indian Immunologicals
4.11.1 Indian Immunologicals Corporation Information
4.11.2 Indian Immunologicals Description, Business Overview
4.11.3 Indian Immunologicals Human Rabies Vaccine Products Offered
4.11.4 Indian Immunologicals Human Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Indian Immunologicals Human Rabies Vaccine Revenue by Product
4.11.6 Indian Immunologicals Human Rabies Vaccine Revenue by Application
4.11.7 Indian Immunologicals Human Rabies Vaccine Revenue by Geographic Area
4.11.8 Indian Immunologicals Recent Development
5 Breakdown Data by Type
5.1 Global Human Rabies Vaccine Sales by Type (2016-2027)
5.1.1 Global Human Rabies Vaccine Sales by Type (2016-2021)
5.1.2 Global Human Rabies Vaccine Sales Forecast by Type (2022-2027)
5.1.3 Global Human Rabies Vaccine Sales Market Share by Type (2016-2027)
5.2 Global Human Rabies Vaccine Revenue Forecast by Type (2016-2027)
5.2.1 Global Human Rabies Vaccine Revenue by Type (2016-2021)
5.2.2 Global Human Rabies Vaccine Revenue Forecast by Type (2022-2027)
5.2.3 Global Human Rabies Vaccine Revenue Market Share by Type (2016-2027)
5.3 Human Rabies Vaccine Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Human Rabies Vaccine Sales by Application (2016-2027)
6.1.1 Global Human Rabies Vaccine Sales by Application (2016-2021)
6.1.2 Global Human Rabies Vaccine Sales Forecast by Application (2022-2027)
6.1.3 Global Human Rabies Vaccine Sales Market Share by Application (2016-2027)
6.2 Global Human Rabies Vaccine Revenue Forecast by Application (2016-2027)
6.2.1 Global Human Rabies Vaccine Revenue by Application (2016-2021)
6.2.2 Global Human Rabies Vaccine Revenue Forecast by Application (2022-2027)
6.2.3 Global Human Rabies Vaccine Revenue Market Share by Application (2016-2027)
6.3 Human Rabies Vaccine Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Human Rabies Vaccine Market Size YoY Growth 2016-2027
7.2 North America Human Rabies Vaccine Market Facts & Figures by Country
7.2.1 North America Human Rabies Vaccine Sales by Country (2016-2027)
7.2.2 North America Human Rabies Vaccine Revenue by Country (2016-2027)
7.3 North America Human Rabies Vaccine Sales by Type
7.4 North America Human Rabies Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Human Rabies Vaccine Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Human Rabies Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Human Rabies Vaccine Sales by Region (2016-2027)
8.2.2 Asia-Pacific Human Rabies Vaccine Revenue by Region (2016-2027)
8.3 Asia-Pacific Human Rabies Vaccine Sales by Type
8.4 Asia-Pacific Human Rabies Vaccine Sales by Application
9 Europe
9.1 Europe Human Rabies Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Human Rabies Vaccine Market Facts & Figures by Country
9.2.1 Europe Human Rabies Vaccine Sales by Country (2016-2027)
9.2.2 Europe Human Rabies Vaccine Revenue by Country (2016-2027)
9.3 Europe Human Rabies Vaccine Sales by Type
9.4 Europe Human Rabies Vaccine Sales by Application
10 Latin America
10.1 Latin America Human Rabies Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Human Rabies Vaccine Market Facts & Figures by Country
10.2.1 Latin America Human Rabies Vaccine Sales by Country (2016-2027)
10.2.2 Latin America Human Rabies Vaccine Revenue by Country (2016-2027)
10.3 Latin America Human Rabies Vaccine Sales by Type
10.4 Latin America Human Rabies Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Human Rabies Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Human Rabies Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Rabies Vaccine Sales by Country (2016-2027)
11.2.2 Middle East and Africa Human Rabies Vaccine Revenue by Country (2016-2027)
11.3 Middle East and Africa Human Rabies Vaccine Sales by Type
11.4 Middle East and Africa Human Rabies Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Human Rabies Vaccine Supply Chain Analysis
12.2 Human Rabies Vaccine Key Raw Materials and Upstream Suppliers
12.3 Human Rabies Vaccine Clients Analysis
12.4 Human Rabies Vaccine Sales Channel and Sales Model Analysis
12.4.1 Human Rabies Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Human Rabies Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Human Rabies Vaccine Distributors
13 Market Dynamics
13.1 Human Rabies Vaccine Market Drivers
13.2 Human Rabies Vaccine Market Opportunities
13.3 Human Rabies Vaccine Market Challenges
13.4 Human Rabies Vaccine Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Human Rabies Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Vero Cell
Table 3. Major Manufacturers of BHK
Table 4. Major Manufacturers of Chick Embryo Cell
Table 5. Major Manufacturers of Human Diploid Cells
Table 6. Major Manufacturers of Others
Table 7. Global Human Rabies Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 8. Global Human Rabies Vaccine Market Size by Region (US$ Million): 2021 VS 2027
Table 9. Global Human Rabies Vaccine Sales by Region (2016-2021) & (K Units)
Table 10. Global Human Rabies Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Human Rabies Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Human Rabies Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Human Rabies Vaccine Sales by Manufacturer (2016-2021) & (K Units)
Table 14. Global Human Rabies Vaccine Sales Share by Manufacturer (2016-2021)
Table 15. Human Rabies Vaccine Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 16. Human Rabies Vaccine Revenue Share by Manufacturer (2016-2021)
Table 17. Key Manufacturers Human Rabies Vaccine Price (2016-2021) & (US$/Unit)
Table 18. Ranking of Global Top Human Rabies Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 19. Global Human Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Human Rabies Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Rabies Vaccine as of 2020)
Table 21. Human Rabies Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Rabies Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Human Rabies Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Bharat Biotech Corporation Information
Table 26. Bharat Biotech Description and Business Overview
Table 27. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 28. Bharat Biotech Human Rabies Vaccine Product
Table 29. Bharat Biotech Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 30. Bharat Biotech Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 31. Bharat Biotech Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 32. Bharat Biotech Human Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 33. Bharat Biotech Recent Development
Table 34. Bavarian Nordic Corporation Information
Table 35. Bavarian Nordic Description and Business Overview
Table 36. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 37. Bavarian Nordic Human Rabies Vaccine Product
Table 38. Bavarian Nordic Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 39. Bavarian Nordic Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 40. Bavarian Nordic Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 41. Bavarian Nordic Human Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 42. Bavarian Nordic Recent Development
Table 43. Sanofi-Pasteur Corporation Information
Table 44. Sanofi-Pasteur Description and Business Overview
Table 45. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 46. Sanofi-Pasteur Human Rabies Vaccine Product
Table 47. Sanofi-Pasteur Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 48. Sanofi-Pasteur Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 49. Sanofi-Pasteur Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 50. Sanofi-Pasteur Human Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 51. Sanofi-Pasteur Recent Development
Table 52. Chengda Bio Corporation Information
Table 53. Chengda Bio Description and Business Overview
Table 54. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 55. Chengda Bio Human Rabies Vaccine Product
Table 56. Chengda Bio Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 57. Chengda Bio Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 58. Chengda Bio Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 59. Chengda Bio Human Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 60. Chengda Bio Recent Development
Table 61. KANGH Corporation Information
Table 62. KANGH Description and Business Overview
Table 63. KANGH Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 64. KANGH Human Rabies Vaccine Product
Table 65. KANGH Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 66. KANGH Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 67. KANGH Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 68. KANGH Human Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 69. KANGH Recent Development
Table 70. Prcmise Corporation Information
Table 71. Prcmise Description and Business Overview
Table 72. Prcmise Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 73. Prcmise Human Rabies Vaccine Product
Table 74. Prcmise Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 75. Prcmise Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 76. Prcmise Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 77. Prcmise Recent Development
Table 78. Henan Grand Biopharma Corporation Information
Table 79. Henan Grand Biopharma Description and Business Overview
Table 80. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Henan Grand Biopharma Human Rabies Vaccine Product
Table 82. Henan Grand Biopharma Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 83. Henan Grand Biopharma Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 84. Henan Grand Biopharma Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 85. Henan Grand Biopharma Recent Development
Table 86. Zhuoyi Biological Corporation Information
Table 87. Zhuoyi Biological Description and Business Overview
Table 88. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 89. Zhuoyi Biological Human Rabies Vaccine Product
Table 90. Zhuoyi Biological Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 91. Zhuoyi Biological Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 92. Zhuoyi Biological Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 93. Zhuoyi Biological Recent Development
Table 94. ZhongKe Biopharm Corporation Information
Table 95. ZhongKe Biopharm Description and Business Overview
Table 96. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 97. ZhongKe Biopharm Human Rabies Vaccine Product
Table 98. ZhongKe Biopharm Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 99. ZhongKe Biopharm Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 100. ZhongKe Biopharm Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 101. ZhongKe Biopharm Recent Development
Table 102. Ningbo Rongan Biological Corporation Information
Table 103. Ningbo Rongan Biological Description and Business Overview
Table 104. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. Ningbo Rongan Biological Human Rabies Vaccine Product
Table 106. Ningbo Rongan Biological Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 107. Ningbo Rongan Biological Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 108. Ningbo Rongan Biological Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 109. Ningbo Rongan Biological Recent Development
Table 110. Indian Immunologicals Corporation Information
Table 111. Indian Immunologicals Description and Business Overview
Table 112. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Indian Immunologicals Human Rabies Vaccine Product
Table 114. Indian Immunologicals Human Rabies Vaccine Revenue (US$ Million) and Market Share by Product
Table 115. Indian Immunologicals Human Rabies Vaccine Revenue (US$ Million) and Market Share by Application
Table 116. Indian Immunologicals Human Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 117. Indian Immunologicals Recent Development
Table 118. Global Human Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 119. Global Human Rabies Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 120. Global Human Rabies Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 121. Global Human Rabies Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 122. Global Human Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 123. Global Human Rabies Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 124. Global Human Rabies Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 125. Global Human Rabies Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 126. North America Human Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 127. North America Human Rabies Vaccine Sales by Country (2022-2027) & (K Units)
Table 128. North America Human Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 129. North America Human Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 130. North America Human Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 131. North America Human Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 132. Asia-Pacific Human Rabies Vaccine Sales by Region (2016-2021) & (K Units)
Table 133. Asia-Pacific Human Rabies Vaccine Sales by Region (2022-2027) & (K Units)
Table 134. Asia-Pacific Human Rabies Vaccine Revenue by Region (2016-2027) & (US$ Million)
Table 135. Asia-Pacific Human Rabies Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 136. Asia-Pacific Human Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 137. Asia-Pacific Human Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 138. Europe Human Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 139. Europe Human Rabies Vaccine Sales by Country (2022-2027) & (K Units)
Table 140. Europe Human Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 141. Europe Human Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 142. Europe Human Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 143. Europe Human Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 144. Latin America Human Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 145. Latin America Human Rabies Vaccine Sales by Country (2022-2027) & (K Units)
Table 146. Latin America Human Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 147. Latin America Human Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 148. Latin America Human Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 149. Latin America Human Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 150. Middle East and Africa Human Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 151. Middle East and Africa Human Rabies Vaccine Sales by Country (2022-2027) & (K Units)
Table 152. Middle East and Africa Human Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 153. Middle East and Africa Human Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 154. Middle East and Africa Human Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 155. Middle East and Africa Human Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 156. Human Rabies Vaccine Key Raw Materials, Industry Status and Trend
Table 157. Human Rabies Vaccine Key Raw Materials and Upstream Suppliers
Table 158. Human Rabies Vaccine Clients Status and Trend
Table 159. Human Rabies Vaccine Typical Clients
Table 160. Human Rabies Vaccine Distributors
Table 161. Key Drivers: Impact Analysis (2022-2027)
Table 162. Human Rabies Vaccine Market Drivers
Table 163. Human Rabies Vaccine Market Opportunities
Table 164. Human Rabies Vaccine Market Challenges
Table 165. Human Rabies Vaccine Market Restraints
Table 166. Human Rabies Vaccine Porter's Five Forces Analysis
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rabies Vaccine Product Picture
Figure 2. Global Human Rabies Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Vero Cell Product Picture
Figure 4. BHK Product Picture
Figure 5. Chick Embryo Cell Product Picture
Figure 6. Human Diploid Cells Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Rabies Vaccine Sales Market Share by Application in 2021 & 2027
Figure 9. Pre-Exposure Vaccine Examples
Figure 10. Post-Exposure Vaccine Examples
Figure 11. Human Rabies Vaccine Report Years Considered
Figure 12. Global Human Rabies Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Human Rabies Vaccine Market Size 2016-2027 (US$ Million)
Figure 14. Global Human Rabies Vaccine Sales 2016-2027 (K Units)
Figure 15. Global Human Rabies Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Human Rabies Vaccine Sales Market Share Forecast by Region (2016-2027)
Figure 17. Global Human Rabies Vaccine Revenue Market Share by Region (2016-2027)
Figure 18. Global Human Rabies Vaccine Sales Share by Manufacturer in 2020
Figure 19. Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Human Rabies Vaccine Sales Market Share Forecast by Type (2016-2027)
Figure 21. Global Human Rabies Vaccine Revenue Market Share Forecast by Type (2016-2027)
Figure 22. Human Rabies Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 23. Global Human Rabies Vaccine Sales Market Share Forecast by Application (2016-2027)
Figure 24. Global Human Rabies Vaccine Revenue Market Share Forecast by Application (2016-2027)
Figure 25. Human Rabies Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 26. North America Human Rabies Vaccine Revenue 2016-2027 (US$ Million)
Figure 27. North America Human Rabies Vaccine Sales Market Share by Type (2016-2021)
Figure 28. North America Human Rabies Vaccine Sales Market Share by Application (2016-2021)
Figure 29. Asia-Pacific Human Rabies Vaccine Revenue 2016-2027 (US$ Million)
Figure 30. Asia-Pacific Human Rabies Vaccine Sales Market Share by Region (2016-2027)
Figure 31. Asia-Pacific Human Rabies Vaccine Revenue Market Share by Region (2016-2027)
Figure 32. Asia-Pacific Human Rabies Vaccine Sales Market Share by Type (2016-2021)
Figure 33. Asia-Pacific Human Rabies Vaccine Sales Market Share by Application (2016-2021)
Figure 34. Europe Human Rabies Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. Europe Human Rabies Vaccine Sales Market Share by Country (2016-2027)
Figure 36. Europe Human Rabies Vaccine Revenue Market Share by Country (2016-2027)
Figure 37. Europe Human Rabies Vaccine Sales Market Share by Type (2016-2021)
Figure 38. Europe Human Rabies Vaccine Sales Market Share by Application (2016-2021)
Figure 39. Latin America Human Rabies Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 40. Latin America Human Rabies Vaccine Sales Market Share by Country (2016-2027)
Figure 41. Latin America Human Rabies Vaccine Revenue Market Share by Country (2016-2021)
Figure 42. Latin America Human Rabies Vaccine Sales Market Share by Type (2016-2021)
Figure 43. Latin America Human Rabies Vaccine Sales Market Share by Application (2016-2021)
Figure 44. Middle East and Africa Human Rabies Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 45. Middle East and Africa Human Rabies Vaccine Sales Market Share by Country (2016-2027)
Figure 46. Middle East and Africa Human Rabies Vaccine Revenue Market Share by Country (2016-2027)
Figure 47. Middle East and Africa Huma

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs